← Back to Search

Procedure

HydraSolve T2D™ for Type 2 Diabetes

N/A
Waitlist Available
Led By Ralph DeFronzo, MD
Research Sponsored by Medality Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 1 year study completion
Awards & highlights

Study Summary

This study is evaluating whether a minimally invasive surgery may help improve blood glucose control and insulin resistance in patients with obesity and type 2 diabetes.

Eligible Conditions
  • Type 2 Diabetes
  • Insulin Resistance

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 1 year study completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 1 year study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lack of serious adverse events (SAEs)
Secondary outcome measures
Change in Insulin Sensitivity
Change in blood glucose control
Body Weight Changes
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intra-Abdominal Mesenteric Fat Extraction GroupExperimental Treatment1 Intervention
All enrolled patients will undergo the combined minimally invasive laparoscopic and mini-laparotomy procedure to selectively extract excess intra-abdominal fat from the mesentery.

Find a Location

Who is running the clinical trial?

Medality MedicalLead Sponsor
Ralph DeFronzo, MDPrincipal InvestigatorUniversity of Texas
11 Previous Clinical Trials
1,102 Total Patients Enrolled
Mark Andrew, MDStudy DirectorMedality Medical

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes
2019. "Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03953963.
All > Type 2 Diabetes
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top